Semprus Biosciences

Semprus Biosciences is a startup based in the United States. Semprus Biosciences has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Developed surface-modifying polymer technologies (branded Endexo) to reduce thrombosis and biofilm formation on blood-contacting medical devices such as catheters. The company's technology was applied to improve device hemocompatibility and reduce infection and occlusion risk for medical device manufacturers.